BioSpace News Archive

VitalSight, the first remote patient monitoring service by OMRON, is designed specifically for hypertension management and can integrate patient data directly into the electronic medical record

Censinet, the leading provider of healthcare IT risk solutions, today announced a partnership with MassChallenge HealthTech, a digital health collaboration program for startups, industry partners, and government agencies.

Applied Spectral Imaging (ASI) and KromaTiD, Inc. announced today that they have entered into a strategic commercial partnership, granting ASI worldwide rights to market KromaTiD’s proprietary Pinpoint FISH™ (PPF) probes and assay services. PPF is used by researchers around the world to directly analyze unique a

Apotheka Systems Inc. announced they have been awarded a critical Patent “Methods, Systems, and Storage Media For Managing Patient Information Using a Blockchain Network” by the U.S. Patent and Trademark Office (“USPTO”) U.S. Patent No. 10,885,170 issued on January 5th, 2021

ANI Pharmaceuticals, Inc. announced that it has acquired the new drug applications for OXISTAT® Lotion, VEREGEN® Ointment, and Pandel® Cream and the abbreviated new drug application for ApexiCon® E Cream from Sandoz Inc. Pandel® Cream will be transitioned later upon receiving the requisite approvals.

Landos Biopharma (NASDAQ: LABP), a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for patients with autoimmune diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for omilancor (BT-11),

Shattuck Labs, Inc., a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, announced it will participate in Needham’s 20th Annual Healthcare Conference being held virtually April 12-15, 2021.

XORTX Therapeutics Inc., a biopharmaceutical company focused on developing therapeutics for the treatment of progressive kidney disease, is pleased to announce that it has received notification of intention to grant the patent “Compositions and Methods for Treatment and Prevention of Hyperuricemia Related Health Consequences” by the European Patent Office for this PCT international application.

Novel Microdevices, Inc. ,(Novel) a developer of an innovative molecular diagnostics platform, announced today that CARB-X has awarded it up to $13 .8 million in non-dilutive funding to develop its next-generation rapid molecular test for the diagnosis of sexually transmitted bacterial infections, including Chlamydia trachomatis

PYC Therapeutics (ASX: PYC), a biotechnology company developing a new generation of precision RNA therapeutics to change the lives of patients with inherited diseases, today announced it will host an investor call on April 15, 2021 at 10 am AEST | 8 am AWST